TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 3 | -2 | -2 | 19 | 2 | -3 | -31 | -3 |
| S | %wins | 100 | 67 | 33 | 67 | 67 | 67 | 67 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/7/06 17:38 | 3/3/06 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bugg Charles E | AL | DO | CB | S.d | -1,032 | 20.64 | 21 | -50 | -27 | 136 | B | 0 | 1 | -8 | -32 | -45 | -47 | ||||||||
9/27/05 18:33 | 9/26/05 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bugg Charles E | AL | DO | CEO,CB | S.d | -950 | 10.00 | 2 | -95 | -42 | 131 | D | 47 | 92 | 117 | 91 | 39 | 16 | 6 | 6 | -2 | 0 | 57 | 81 | 84 | 16 |
4/29/04 14:57 | 4/27/04 | BCRX | Biocryst Pharmaceuticals Inc | DE | Health | BioPrd | Biological Products, (No Diag | Bugg Charles E | AL | DO | CEO | S.d | -808 | 9.51 | 2 | -85 | -40 | 126 | D | 151 | 529 | 18 | 42 | 29 | 28 | 32 | 32 | -4 | -6 | 9 | -43 | -49 | -61 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |